Letrozole for ovulation induction

References

• United Nations. Report of The International Conference on Population and Development, Cairo, Egypt 5–13 September 1994. United Nations Population Fund, NY, USA, E.95.XIII.18 (1995).
   Google Scholar
• Farley TMM, Belsey FH. The prevalence and etiology of infertility. Biological Components of Fertility. Proceedings of the African Population Conference, Dakar, Senegal. International Union for the Scientific Study of Population. Laege, Belgium, l1:2.1.15–2.1.30 (1988).
   Google Scholar
• American Society for Reproductive Medicine. Guidelines for the Provision of Infertility Service. ASRM, AL, USA (1996).
   Google Scholar
• Templeton A. Infertility – epidemiology, aetiology and effective management. Health Bull. (Edinb.)53(5), 294–298 (1995).
   PubMedGoogle Scholar
• Whiteford LM, Gonzalez L. Stigma: the hidden burden of infertility. Soc. Sci. Med.40(1), 27–36 (1995).
   PubMedGoogle Scholar
• Beck JI, Boothroyd C, Proctor M, Farquar C, Hughes E. Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation. Cochrane Database Syst. Rev.25(1), CD002249 (2005).
   Google Scholar
• Speroff L, Glass RH, Kase NG. Female infertility. In: Clinical Gynecologic Endocrinology and Infertility. Williams & Wilkins, MD, USA, 809–840 (1994).
   Google Scholar
• Greenblatt RB, Barfield WE, Jungck EC et al. Induction of ovulation with MRL/41. JAMA178, 101–105 (1961).
   PubMed Web of Science ®Google Scholar
• Mitwally MFM, Casper RF. Aromatase inhibition: a novel method of ovulation induction in women with polycystic ovarian syndrome. Reprod. Technol.10(12), 244–247 (2000).
   Google Scholar
• Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil. Steril.75(2), 305–309 (2001).
   PubMed Web of Science ®Google Scholar
• Mitwally MFM, Casper RF. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil. Steril.77(4), 776–780 (2002).
   PubMed Web of Science ®Google Scholar
• Mitwally MF, Casper RF. Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility. Hum. Reprod.18(8), 1588–1597 (2003).
   PubMed Web of Science ®Google Scholar
• Mitwally MF, Casper RF. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation. J. Soc. Gynecol. Investig.11(6), 406–415 (2004).
   PubMedGoogle Scholar
• Mitwally MFM, Casper RF. Single dose administration of the aromatase inhibitor, letrozole: a simple and convenient effective method of ovulation induction. Fertil. Steril.83(1), 229–231 (2005).
   PubMed Web of Science ®Google Scholar
• Mitwally MF, Biljan MM, Casper RF. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am. J. Obstet. Gynecol.192(2), 381–386 (2005).
   PubMed Web of Science ®Google Scholar
• Sammour A, Biljan MM, Tan SL, Tulandi T. Prospective randomized trial comparing the effects of letrozole (LE) and clomiphene citrate (CC) on follicular development, endometrial thickness and pregnancy rate in patients undergoing super-ovulation prior to intrauterine insemination (IUI). Fertil. Steril.76, S110 (2001).
   Google Scholar
• Fatemi HM, Kolibianakis E, Tournaye H et al. Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study. Reprod. Biomed. Online7(5), 543–546 (2003).
   PubMedGoogle Scholar
• Healey S, Tan SL, Tulandi T et al. Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination. Fertil. Steril.80(6), 1325–1329 (2003).
   PubMed Web of Science ®Google Scholar
• Al-Omari WR, Sulaiman WR, Al-Hadithi N. Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. Int. J. Gynaecol. Obstet.85(3), 289–291 (2004).
   PubMedGoogle Scholar
• Al-Fozan H, Al-Khadouri M, Tan SL et al. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil. Steril.82(6), 1561–1563 (2004).
   PubMedGoogle Scholar
• Goswami SK, Das T, Chattopadhyay et al. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report. Hum. Reprod.19(9), 2031–2035 (2004).
   PubMed Web of Science ®Google Scholar
• Cortinez A, De Carvalho I, Vantman D et al. Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patients. Fertil. Steril.83(1), 110–115 (2005).
   PubMed Web of Science ®Google Scholar
• Oktay K, Buyuk E, Libertella N et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J. Clin. Oncol.23(19), 4347–4353 (2005).
   PubMed Web of Science ®Google Scholar
• Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J. Clin. Oncol.23(16), 3858–3859 (2005).
   PubMed Web of Science ®Google Scholar
• Garcia-Velasco JA, Moreno L, Pacheco A et al. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil. Steril.84(1), 82–87 (2005).
   PubMed Web of Science ®Google Scholar
• Ryan GL, Moss, Davis WA et al. Oral ovulation induction agents combined with low-dose gonadotropin injections and intrauterine insemination: cost- and clinical-effectiveness. J. Reprod. Med.50(12), 943–950 (2005).
   Google Scholar
• Al-Fadhli R, Sylvestre C, Buckett W et al. A randomized trial of superovulation with two different doses of letrozole. Fertil. Steril.85(1), 161–164 (2006).
   PubMed Web of Science ®Google Scholar
• Bayar U, Tanriverdi HA, Barut A et al. Letrozole vs. clomiphene citrate in patients with ovulatory infertility. Fertil. Steril.85(4), 1045–1048 (2006).
   PubMedGoogle Scholar
• Elnashar A, Fouad H, Eldosoky M et al. Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio. Fertil. Steril.85(2), 161–164 (2006).
   Google Scholar
• Atay V, Cam C, Muhcu M et al. Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. J. Int. Med. Res.34(1), 73–76 (2006).
   PubMed Web of Science ®Google Scholar
• Sohrabvand F, Ansari S, Bagheri M. Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Hum. Reprod.21(6), 1432–145 (2006).
   PubMed Web of Science ®Google Scholar
• Jee BC, Ku SY, Suh CS, Kim KC, Lee WD, Kim SH. Use of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles: a pilot study. Fertil. Steril.85(6), 1774–1777 (2006).
   PubMed Web of Science ®Google Scholar
• Gemzell CA, Diczfalusy E, Tillinger KG. Human pituitary follicle stimulating hormone. Clinical effects of partly purified preparation. Ciba Foundation Colloquia Endocrinol.13, 191 (1960).
   Google Scholar
• Bettendorf G, Apostolakis M, Voigt KD. Darstellung hochaktiver Gonadotropinfraktionen aus menschlichen Hypophysen und deren anwendung bei Menschen. Proceedings, International Federation of Gynecology and Obstetrics, Vienna, Austria, 76 (1961).
   Google Scholar
• De Leo V, la Marca A, Petraglia F. Insulin-lowering agents in the management of polycystic ovary syndrome. Endocr. Rev.24(5), 633–667 (2003).
   PubMed Web of Science ®Google Scholar
• Mitwally MFM, Casper RF. Aromatase inhibition for ovarian stimulation: future avenues for infertility management. Curr. Opin. Obstet. Gynecol.14(3), 255–263 (2002).
   PubMed Web of Science ®Google Scholar
• Mitwally MFM, Casper RF. Aromatase inhibitors for the treatment of infertility. Expert Opin. Investig. Drugs12(3), 353–371 (2003).
   PubMed Web of Science ®Google Scholar
• Mitwally MFM, Casper RF. Review: aromatase inhibitors for ovulation induction. J. Clin. Endocrinol. Metab.91(3), 760–771 (2006).
   Google Scholar
• Garcia J, Seegar J G, Wentz AC. The use of clomiphene citrate. Fertil. Steril.28(7), 707–717 (1977).
   PubMed Web of Science ®Google Scholar
• Carlier P, Choulika S, Efthymiou ML. Clomiphene-exposed pregnancies: Analysis of 39 information requests including 25 cases with known outcome. Therapie51(5), 532–536 (1996).
   PubMedGoogle Scholar
• Dickey RP, Taylor SN, Curole DN et al. Incidence of spontaneous abortion in clomiphene pregnancies. Hum. Reprod.11(12), 2642–2648 (1996).
   Google Scholar
• Schieve LA, Tatham L, Peterson HB, Toner J, Jeng G. Spontaneous abortion among pregnancies conceived using assisted reproductive technology in the United States. Obstet. Gynecol.1015(1), 959–967 (2003).
   Google Scholar
• Hakim RB, Gray RH, Zacur H. Infertility and early pregnancy loss. Am. J. Obstet. Gynecol.172(5), 1510–1517 (1995).
   Google Scholar
• Gonen Y, Casper RF. Sonographic determination of an adverse effect of clomiphene citrate on endometrial growth. Hum. Reprod.5(6), 670–674 (1990).
   PubMed Web of Science ®Google Scholar
• Nelson LM, Hershlag A, Kurl RS, Hall JL, Stillman RJ. Clomiphene citrate directly impairs endometrial receptivity in the mouse. Fertil. Steril.53(4), 727–731 (1990).
   PubMedGoogle Scholar
• Li TC, Warren MA, Murphy C, Sargeant S, Cooke ID. A prospective, randomised, cross-over study comparing the effects of clomiphene citrate and cyclofenil on endometrial morphology in the luteal phase of normal fertile women. Br. J. Obstet. Gynaecol.99(12), 1008–1013 (1992).
   Google Scholar
• Fritz MA, Holmes RT, Keenan EJ. Effect of clomiphene citrate treatment on endometrial estrogen and progesterone receptor induction in women. Am. J. Obstet. Gynecol.165(1), 177–185 (1991).
   PubMed Web of Science ®Google Scholar
• Yeko TR, Nicosia SM, Maroulis GB et al. Histology of midluteal corpus luteum and endometrium from clomiphene citrate-induced cycles. Fertil. Steril.57(1), 28–32 (1992).
   PubMed Web of Science ®Google Scholar
• Hsu CC, Kuo HC, Wang ST, Huang KE. Interference with uterine blood flow by clomiphene citrate in women with unexplained infertility. Obstet. Gynecol.866(6), 917–921 (1995).
   Google Scholar
• Oktay K, Berkowitz P, Berkus M, Schenken RS, Brzyski RG. The re-incarnation of an old question clomid effect on oocyte and embryo? Fertil. Steril.74(2), 422–423 (2000).
   PubMed Web of Science ®Google Scholar
• Schmidt GE, Kim MH, Mansour R, Torello L, Friedman CI. The effects of enclomiphene and zuclomiphene citrates on mouse embryos fertilized in vitro and in vivo.Am. J. Obstet. Gynecol.154(4), 727–736 (1986).
   PubMed Web of Science ®Google Scholar
• Yoshimura Y, Hosoi Y, Atlas SJ, Wallach EE. Effect of clomiphene citrate on in vitro ovulated ova. Fertil. Steril.45(6), 800–804 (1986).
   PubMed Web of Science ®Google Scholar
• Ben-Ami M, Geslevich Y, Matilsky M et al. Exogenous estrogen therapy concurrent with clomiphene citrate: Lack of effect on serum sex hormones and endometrial thickness. Gynecol. Obstet. Invest.37(3), 180–184 (1994).
   PubMed Web of Science ®Google Scholar
• Gonen Y, Casper RF. Sonographic determination of an adverse effect of clomiphene citrate on endometrial growth. Hum. Reprod.5(6), 670–674 (1990).
   PubMed Web of Science ®Google Scholar
• Dawood MY. In vitro fertilization, gamete intrafallopian transfer and superovulation with intra-uterine insemination: efficacy and potential health hazards on babies delivered. Am. J. Obstet. Gynecol.174(4), 1208–1217 (1996).
   PubMed Web of Science ®Google Scholar
• Martin JA, Hamilton BE, Ventura SJ, Menacker F, Park MM, Sutton PD. Births: final data for 2001. Nat. Vital Stat. Rep.51(2), 1–102 (2002).
   Google Scholar
• Lipitz S, Frenkel Y, Watts C, Ben-Rafael Z, Barkai G, Reichman B. High-order multifetal gestation – management and outcome. Obstet. Gynecol.76(2), 215–218 (1990).
   PubMedGoogle Scholar
• Callahan L, Hall JE, Ettner SL, Christiansen CL, Greene MF, Crowley WF. The economic impact of multiple-gestation pregnancies and the contribution of assisted-reproduction techniques to their incidence. N. Engl. J. Med.331(4), 244–249 (1994).
   PubMed Web of Science ®Google Scholar
• Wapner RJ, Davis GH, Johnson A et al. Selective reduction of multifetal pregnancies. Lancet335(8681), 90–93 (1990).
   PubMedGoogle Scholar
• Adashi EY, Barri PN, Berkowitz R et al. Infertility therapy-associated multiple pregnancies births: an ongoing epidemic. Reprod. Biomed. Online.7(5), 515–542 (2003).
   PubMedGoogle Scholar
• Wysowski DE. Use of fertility drugs in the United States, 1979 through 1991. Fertil. Steril.60(6), 1096–1098 (1993).
   PubMed Web of Science ®Google Scholar
• Rossing MA, Daling JR, Weiss NS et al. Ovarian tumors in a cohort of infertile women. N. Engl. J. Med.331(12), 771–776 (1994).
   PubMed Web of Science ®Google Scholar
• Venn A, Watson L, Lumley J et al. Breast and ovarian cancer incidence after infertility and in vitro fertilization. Lancet346(8981), 995–1000 (1995).
   PubMed Web of Science ®Google Scholar
• Potashnik G, Lerner-Geva L, Genkin L et al. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil. Steril.71(5), 653–659 (1999).
   Google Scholar
• Cole PA, Robinson CH. Mechanism and inhibition of cytochrome P-450 aromatase. J. Med. Chem.33(11), 2933–2944 (1999).
   Google Scholar
• Naftolin F, MacLusky NJ, Leranth CZ et al. The cellular effects of estrogens on neuroendocrine tissues. J. Steroid. Biochem.30(1–6), 195–107 (1988).
   PubMedGoogle Scholar
• Roberts V, Meunier H, Vaughan J et al. Production and regulation of inhibin subunits in pituitary gonadotropes. Endocrinology124(1), 552–554 (1989).
   PubMed Web of Science ®Google Scholar
• Mason AJ, Berkemeier LM, Schmelzer CH et al. Activin B: precursor sequences, genomic structure and in vitro activities. Mol. Endocrinol.3(9), 1352–1358 (1989).
   Google Scholar
• Weil SJ, Vendola K, Zhou J et al. Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J. Clin. Endocrinol. Metab.83(7), 2479–2485 (1989).
   Google Scholar
• Weil S, Vendola K, Zhou J et al. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J. Clin. Endocrinol. Metab.84(8), 2951–2956 (1999).
   PubMed Web of Science ®Google Scholar
• Vendola KA, Zhou J, Adesanya OO et al. Androgens stimulate early stages of follicular growth in the primate ovary. J. Clin. Invest.101(12), 2622–2629 (1998).
   PubMed Web of Science ®Google Scholar
• Goss PE. Risks versus benefits in the clinical application of aromatase inhibitors. Endocr. Relat. Cancer6(2), 325–332 (1999).
   PubMed Web of Science ®Google Scholar
• Palter SF, Tavares AB, Hourvitz A et al. Are Estrogens of Import to Primate/Human Ovarian Folliculogenesis? Endocr. Rev.22(3), 389–424 (2001).
   PubMed Web of Science ®Google Scholar
• Biljan MM, Hemmings R, Brassard N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil. Steril.84(Suppl.1), 0–231 (2005).
   Google Scholar
• Tulandi T, Al-Fadhli R, Kabli N et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil. Steril.85(6), 1761–1765 (2006).
   PubMed Web of Science ®Google Scholar
• Hoffman JIE. Incidence of congenital heart disease: I. Postnatal incidence. Pediatr. Cardiol.16(3), 103–113 (1995).
   PubMed Web of Science ®Google Scholar
• Mouridsen HT, Bhatnagar AS. 24: Letrozole in the treatment of breast cancer. Expert Opin. Pharmacother.6(8), 1389–1399 (2005).
   PubMed Web of Science ®Google Scholar
• Letrozole package insert prescribing information.
   Google Scholar
• Haynes BP, Dowsett M, Miller WR, Dixon JM, Bhatnagar AS. The pharmacology of letrozole. J. Steroid. Biochem. Mol. Biol.87(1), 35–45 (2003).
   PubMed Web of Science ®Google Scholar
• Miller WR. Aromatase inhibitors and breast cancer. Minerva Endocrinol.31(1), 27–46 (2006).
   PubMedGoogle Scholar